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doi:10.1016/j.gmbhs.2012.04.021Abstract Serum carcinoembryonic antigen (CEA) is most commonly used as a prognostic
biomarker for evaluating curatively resected colorectal cancer (CRC) patients, but it has
a low sensitivity and specificity. The aim of this study was to evaluate potential genetic
markers in CRC patients using membrane array. Fifty CRC patients were enrolled and mRNA
expression in their tissues were analyzed using membrane array analysis. Seven genes were
analyzed in this study, including ATP2A2, GLUT1, MMP13, MAGE-A2, MAGE-A7, MAGE-A8,
and MAGE-A12. Correlations between the results of the membrane array and the clinicopath-
ological features of these CRC patients were then evaluated. The results show that the over-
expression of any three or four of these seven genes is correlated with tumor invasion depth,
lymphatic invasion, advanced stage, and postoperative recurrence (all p < 0.005). Further-
more, the expression of any four genes was more significantly correlated with clinicopatholog-
ical characteristics than the expression of only two or three genes. The combination of
multiple molecular markers and the membrane array method might be useful for predicting
postoperative relapse in CRC patients.
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commonly used as a prognostic biomarker in curativelyColorectal cancer (CRC) is one of the most common cancers
in the world. About 80% of CRC patients receive curative
resection, but 40e50% of these patients experience recur-
rence within 5 years.1 In fact, 20e25% of patients with
stage II CRC develop recurrence.2 The liver and lungs are
the most frequent sites of metastasis in CRC patients.3
Approximately 80e90% of patients with liver metastasis
are diagnosed with unresectable disease.2 The combination
of chemotherapy and targeted therapy elevates the overall
survival time to 12e20 months, but the 2-year survival rate
is still <40%.4Table 1 Probe sequences of the mRNA markers used in this stu
Gene Oligonucleotide seq
ATP2A2 CATTCAAATACCCCC
GLUT1 CAACCCCACTTACTT
MMP13 TAGAGATCCTCCATT
MAGE-A2 GGATTGTCTCCAAA
MAGE-A7 CTGCCCAAAGAAAC
MAGE-A8 AGCAGCTTCCTGAG
MAGE-A12 TGATCTTTAGCAAAT
TB* GAGTTCACGGATAT
b-actin TGCATTGTTACAGG
TB*: gene of Mycobacterium tuberculosis (negative control).
Figure 1 Schematic representation of the membrane array and c
colorectal cancer patient and a normal control. (A) Schematic repre
including ATP2A2, GLUT1, MMP13, MAGE-A2, MAGE-A7, MAGE-A8, a
tuberculosis gene (negative control); B: DMSO (blank control). (B)
and a healthy control (right). The spot within the red circle indicaSerum carcinoembryonic antigen (CEA) is most
resected CRC patients. However, the weakness of CEA is its
low sensitivity and specificity. Because a single biomarker
only can provide limited sensitivity and specificity, the
combination of multiple biomarkers might be able to
improve diagnosis in these patients. Wang et al analyzed
the expression levels of four genes in peripheral blood
samples from CRC patients, and the sensitivity was 92.4% if
any one of the four genes was overexpressed.5 While all
four genes were overexpressed, the specificity was high as
100%. The study by Shariat et al suggested that multiple
molecular markers can predict the recurrence of bladderdy.
uence (50 / 30)
ACAGGACCATTCCACACAATCTGCTTAGCCCGAGT
CTGTCTCACTCCCATCCAAACCTCCTACCCTCAAT
TCATTACTCTAACATTCTTCAATGTGGTTCCAGCC
GAGTGTAGTTGATGGTAGTCGAGAAGCTGGAGGCTC
TGCTCCATCCCATCATACACCATTACACTCAACGCT
CTTCCAATAGACACTGTGCTCCCTCCCATCATACAG
GGTGCAGGACTTTCACATAGCTGGTTTCAACGAGG
TGCGTTCGATACTGCTGGCGATGAGTTCGAGGACAT
AAGTCCCTTGCCATCCTAAAAGCCACCCCACTTCTCTCTAAGGAGA
omparisons of the gene expression patterns between a human
sentation of the membrane array with the seven target genes,
nd MAGE-A12. P: b-actin (positive control); N: Mycobacterium
Gene expression patterns of a colorectal cancer patient (left)
tes b-actin (positive control).
32 T.-C. Tung et al.cancer more significantly than any single molecular
marker.6
Our recent investigations indicated that the ATP2A2,
GLUT1, MMP13, MAGE-A2, MAGE-A7, MAGE-A8, and MAGE-
A12 genes are overexpressed inCRCpatients.7e10 In addition,
the use of a multimarker assay based on membrane array
analysis, which we had previously developed, demonstrated
the advantages of high sensitivity and specificity. Thus, the
aim of this study was to analyze a panel of seven molecular
markers in CRC patients using the constructed membrane
array method and to evaluate their correlation with the
clinicopathological features of patients.Materials and methods
Fifty CRC patients who had undergone surgical resection
were recruited from Kaohsiung Medical University Hospital.
Total RNA was purified from tumor and normal tissues, and
first strand cDNA was synthesized using an Reverse Tran-
scription System (Promega Corporation, Madison, WI, USA).
We used VectorNTI software (Life Technologies Corp., Grand
Island, NY, USA) to design the sequences of the oligonucle-
otide probes (Table 1). The newly synthesized oligonucleo-
tide fragments were dissolved in deionized distilled waterTable 2 Expression levels of multiple genetic markers in tissue
Two genes# T
P N p P
Gender
Female 25 3 0.621 17
Male 21 1 19
Age (y)
＜60 12 2 0.310
S60 34 2 27
Size
＜5 cm 25 4 0.129 18
S5 cm 21 0 18
Location
Colon 34 1 0.075 27
Rectum 12 3
Depth
T1 þ T2 3 0.004*
T3 þ T4 43 1 34
Lymph node metastasis
Negative 19 3 0.308 11
Positive 27 1 25
UICC stage
I þ II 17 3 0.289
III þ IV 29 1 27
Postoperative metastasis
Negative 23 2 1.000 14
Positive 23 2 22
* p < 0.05.
# Indicates any 2, 3, or 4 out of 7 genes showing overexpression.
UICC Z International Union Against Cancer.and then blotted on Nytran SuPerCharge nylon membrane
(Schleicher and Schuell, Dassel, Germany) in triplicate.
Dimethyl sulfoxide (DMSO) was also dispensed onto the
membrane as a blank control. After rapid drying and cross-
linking procedures, the preparation of the gene chip was
complete. The procedure of the membrane array was per-
formed based on our previously described protocol.9
Subsequent quantification analysis of each spot’s intensity
was carried out using AlphaEase FC software (Alpha Innotech
Corp., San Leandro, CA USA). The spots that consistently
carried a factor of 2 were considered to be differentially
expressed. For each sample, the membrane array hybrid-
ization experiment was performed in triplicate in order to
ensure the reproducibility of results. The fold ratio of each
gene was calculated as follows: spot intensity ratio Z
statistical analysis using Statistical Package for the Social
Sciences software (version 12.0; SPSS Inc., Chicago, IL,
USA). Statistical significance was defined as p < 0.05.Results
Fifty paired tissues (tumor and normal) obtained from the
CRC patients were analyzed using the membrane array, the
diagram of which is shown in Fig. 1. In the combinations obtained from 50 colorectal cancer patients.
hree genes# Four genes#
N p P N p
11 0.061 12 16 0.166
3 14 8
5 0.496 7 1.000
9 19 17
11 0.110 12 17 0.093
3 14 7
8 0.304 18 17 1.000
6 7
4 0.044* 6 0.008*
10 26 18
11 0.004* 17 <0.0001*
3 21 7
11 0.001* 17 <0.0001*
3 23 7
11 0.025* 16 0.046*
3 17 8
Multiple markers of colorectal cancer prognosis 33analysis of the seven genes, the overexpression of any two
genes was correlated with tumor invasion depth
(p Z 0.004) and the overexpression of any three or four
genes was correlated with tumor invasion depth (pZ 0.044
and p < 0.008, respectively), lymphatic invasion (pZ 0.004
and p < 0.0001), advanced tumor stage (p Z 0.001 and
p < 0.0001), and postoperative recurrence (p Z 0.025 and
p Z 0.046; Table 2).
Discussion
Our developed membrane array demonstrates high sensi-
tivity and specificity,11 and because of this advantage
multiple genetic markers can be analyzed quickly and
simultaneously. In this study, we analyzed the expression
levels of seven genes in 50 CRC patients. The results indi-
cate that the overexpression of any three of these seven
genes is correlated with tumor invasion depth, lymphatic
invasion, advanced tumor stage, and postoperative recur-
rence. Furthermore, the overexpression of any four genes
was more significantly correlated with these clinicopatho-
logical characteristics than any two or three genes.
The treatment of colorectal cancer mainly consists of
surgical resection. However, residual cancer cells left
over from surgery may cause micrometastasis, resulting in
the patient developing local recurrent or distance
metastasis. Therefore, effectively evaluating patient
prognosis is very important. The results of this study
indicate that the multimarker membrane array we
developed demonstrates significant correlation between
many clinicopathological characteristics, including tumor
invasion depth, lymphatic invasion, and postoperative
metastasis.
In recent years, many studies have focused on the
correlation between a single mRNA marker and cancer.
Although they provided information on the usefulness of
many markers, one of the limitations is that that analysis of
a single marker can only provide limited sensitivity and
specificity.12e15 Because of the heterogeneous expression
of tumor-related genes, it is generally believed that mul-
timarker assays are more reliable, sensitive, and specific
than single-marker assay.
In brief, we combined seven genetic markers to
construct a new diagnostic platform that uses a membrane
array. The expression levels of these genes demonstrate
correlations with the clinicopathological characteristics of
CRC patients, making these genes potentially useful for
determining the prognosis of colorectal cancer patients
who have undergone surgical resection. However, addi-
tional research on larger patient populations are required
in order to evaluate the sensitivity and specificity, and long-term follow-up examinations are needed to confirm the
clinical significance of this diagnostic platform.References
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